Assignee
ICOS CORP
US·159 granted patents·28 pending applications·4,856 citations·filing 1975–2020
Top patents by PatentIndex Score
187 records- 0198US8980901B25-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 17, 2015·39 cites·21 claims
- 0298USRE44599EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 12, 2013·44 cites·6 claims
- 0398US7932260B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2005·Granted Apr 26, 2011·221 cites·2 claims
- 0498US6949535B2Inhibitors of human phosphatidyl-inositol 3-kinase deltaICOS CORP·Filed 2003·Granted Sep 27, 2005·172 cites·15 claims
- 0598US6667300B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Dec 23, 2003·174 cites·12 claims
- 0698US6518277B1Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Feb 11, 2003·272 cites·13 claims
- 0798US5859006ATetracyclic derivatives; process of preparation and useICOS CORP·Filed 1995·Granted Jan 12, 1999·208 cites·15 claims
- 0897US8779131B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Jul 15, 2014·30 cites·10 claims
- 0997US8586597B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 19, 2013·36 cites·6 claims
- 1097US6521619B2Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agentsICOS CORP·Filed 2001·Granted Feb 18, 2003·103 cites·9 claims
- 1196US8993583B25-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 31, 2015·22 cites·13 claims
- 1296US5888809AHamster EF-1α transcriptional regulatory DNAICOS CORP·Filed 1997·Granted Mar 30, 1999·221 cites·29 claims
- 1395US10010550B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2017·Granted Jul 3, 2018·11 cites·2 claims
- 1495US9487772B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Nov 8, 2016·19 cites·1 claims
- 1595US9149477B25-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2014·Granted Oct 6, 2015·17 cites·12 claims
- 1695US5985589ALipid kinaseICOS CORP·Filed 1999·Granted Nov 16, 1999·171 cites·5 claims
- 1795US5858753ALipid kinaseICOS CORP·Filed 1996·Granted Jan 12, 1999·191 cites·10 claims
- 1894US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 1994US6043252ACarboline derivativesICOS CORP·Filed 1998·Granted Mar 28, 2000·90 cites·14 claims
- 2093US6348602B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Feb 19, 2002·49 cites·33 claims
- 2193US6306870B1N-cinnamoyl derivatives of beta-carbolineICOS CORP·Filed 2000·Granted Oct 23, 2001·63 cites·22 claims
- 2292US10398695B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2018·Granted Sep 3, 2019·5 cites·2 claims
- 2392US6268477B1Chemokine receptor 88-CICOS CORP·Filed 1996·Granted Jul 31, 2001·77 cites·1 claims
- 2492US6265184B1Polynucleotides encoding chemokine receptor 88CICOS CORP·Filed 1995·Granted Jul 24, 2001·75 cites·11 claims
- 2591US10695349B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2019·Granted Jun 30, 2020·2 cites·2 claims
- 2691US10336756B2(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2015·Granted Jul 2, 2019·5 cites·2 claims
- 2791US6486186B2Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the sameICOS CORP·Filed 2001·Granted Nov 26, 2002·43 cites·5 claims
- 2891US6203790B1Platelet-activating factor acetylhydrolaseICOS CORP·Filed 2000·Granted Mar 20, 2001·21 cites·2 claims
- 2991US6143746ATetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and useICOS CORP·Filed 1998·Granted Nov 7, 2000·112 cites·13 claims
- 3091US5880268AModulators of the interaction between ICAM-R and αd /CD18ICOS CORP·Filed 1995·Granted Mar 9, 1999·78 cites·1 claims
- 3190US6372777B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 16, 2002·36 cites·26 claims
- 3290US5882910ALipid kinaseICOS CORP·Filed 1997·Granted Mar 16, 1999·64 cites·1 claims
- 3389US7067506B2Compounds useful for inhibiting Chk1ICOS CORP·Filed 2002·Granted Jun 27, 2006·31 cites·25 claims
- 3489US6797811B1Antibodies to chemokine receptor 88CICOS CORP·Filed 1996·Granted Sep 28, 2004·56 cites·14 claims
- 3589US6458787B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Oct 1, 2002·24 cites·22 claims
- 3689US6432404B1Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodiesICOS CORP·Filed 2000·Granted Aug 13, 2002·38 cites·9 claims
- 3788US7608618B2Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1ICOS CORP·Filed 2005·Granted Oct 27, 2009·9 cites·2 claims
- 3888US6258833B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1999·Granted Jul 10, 2001·55 cites·37 claims
- 3988US6140329AUse of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotenceICOS CORP·Filed 1996·Granted Oct 31, 2000·72 cites·21 claims
- 4088US5932703AMacrophage derived chemokine and chemokine analogsICOS CORP·Filed 1996·Granted Aug 3, 1999·72 cites·5 claims
- 4187US6680336B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted Jan 20, 2004·23 cites·4 claims
- 4287US6444671B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Sep 3, 2002·16 cites·34 claims
- 4386US6294561B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Sep 25, 2001·22 cites·37 claims
- 4486US5981527ACyclic GMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1996·Granted Nov 9, 1999·68 cites·13 claims
- 4585US6734003B2Phosphodiesterase 10ICOS CORP·Filed 2001·Granted May 11, 2004·10 cites·2 claims
- 4685US6569890B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted May 27, 2003·19 cites·28 claims
- 4785US6500856B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Dec 31, 2002·20 cites·4 claims
- 4885US6369059B1Tetracyclic derivatives, process of preparation and useICOS CORP·Filed 2000·Granted Apr 9, 2002·15 cites·3 claims
- 4985US6313156B1Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Nov 6, 2001·20 cites·35 claims
- 5084US7560462B2Compounds useful for inhibiting CHK1ICOS CORP·Filed 2005·Granted Jul 14, 2009·7 cites·3 claims
Showing the top 50 of 187 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ICOS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →